The August DCI Seminar Series will be held Wednesday, Aug. 23, at the Great Hall located in the Trent Seamans Center. Jonathan Licht, MD, director of the University of Florida Health Cancer Center, holding the Marshall E. Rinker, Sr. Foundation and David B. and Leighan R. Rinker Chair, will present: “Disorders of Histone Methylation in Hematological Malignancy.”
A professor of medicine, biochemistry and molecular biology at the University of Florida College of Medicine, Licht’s laboratory studies aberrant gene regulation, specifically the role of abnormal function of histone methyl transferases and histone demethyalses in diseases such as multiple myeloma and is developing small molecule strategies to normalize gene regulation and treat disease.
Funded by the National Cancer Institute for nearly 25 years, Licht is Principal Investigator of a Leukemia and Lymphoma Society Specialized Center and a Multiple Myeloma Research Foundation program grant both in epigenetics. He is also an investigator in the Dana-Farber SPORE in myeloma and co-leader in a NCI-funded Chicago Physical Sciences Oncology Center. Previously, he was Chief of Hematology/Oncology at Northwestern University and an Associate Director of the Robert H. Lurie Comprehensive Cancer Center.
Licht is a Senior Editor of Clinical Cancer Research and serves on the editorial boards of Oncogene and Cancer Cell. He is also a member of the executive committee of the American Society of Hematology, and will be co-director of the 2017 ASH/EHA Translational Research Training program. Additionally he sits on the Medical/Scientific Board of the LLS and is a member of the Basic Mechanisms of Cancer Therapeutics Study Section. He has published nearly 170 original articles, reviews and book chapters, and has mentored more than 40 graduate students and postdoctoral fellows and 20 faculty members.
The lecture begins at 8:10 a.m. and ends at 9 a.m. Licht's address will be preceded by a hematology-oncology fellow presentation starting at 7:30 a.m. The August DCI Seminar Series is presented by the DCI Cancer Genetics and Genomics Program. Duke Cancer Institute members are invited to attend. For more information, contact Erin Carr.